|1.||Froeschle, James E: 2 articles (02/2010 - 11/2007)|
|2.||Date, Kashmira: 1 article (06/2014)|
|3.||Mintz, Eric: 1 article (06/2014)|
|4.||Dawainavesi, Akanisi: 1 article (06/2014)|
|5.||Hyde, Terri B: 1 article (06/2014)|
|6.||Nilles, Eric: 1 article (06/2014)|
|7.||Wannemuehler, Kathleen A: 1 article (06/2014)|
|8.||Korovou, Samuel: 1 article (06/2014)|
|9.||Singh, Sheetalpreet: 1 article (06/2014)|
|10.||Scobie, Heather M: 1 article (06/2014)|
|1.||Typhoid Fever (Typhoid)
06/01/2014 - "During June-December 2010, 64,015 doses of typhoid Vi polysaccharide vaccine were administered to persons ≥ 2 years of age, primarily in cyclone-affected areas that were typhoid endemic. "
12/01/1996 - "Around one-third of travellers to endemic areas receive pre-travel typhoid vaccination, increasingly with the new parenteral vaccination Typhim Vi (Mérieux). "
03/01/1995 - "Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya."
11/01/2007 - "Typhim Vi, a vaccine containing the purified cell surface Vi polysaccharide of the Salmonella enterica serovar Typhi, was developed to provide protection against typhoid fever. "
01/01/2007 - "We emphasize that proper prophylaxis against typhoid fever for travelers should consist of vaccination with two vaccines, oral Ty 21a and parenteral Typhim Vi and it doesn't release travelers from avoiding risky behavior."
|2.||Bacillary Dysentery (Shigellosis)
|4.||Birth Weight (Birth Weights)
|1.||Salmonella capsular polysaccharide
|4.||typhoid Vi polysaccharide vaccine (Typhim Vi)